SCHEMBL24812007

SCHEMBL24812007

c1ccc(-c2cc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)nc(-c3ccc4c5c(cccc35)-c3ccccc3-4)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.41
▸ L3MBTL1 Q9Y468 5/20 0.41
▸ ATM Q13315 1/20 0.41
▸ MAPT P10636 6/20 0.37
▸ ALDH1A1 P00352 6/20 0.37
▸ HPGD P15428 6/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ MEN1 O00255 6/20 0.36
▸ KMT2A Q03164 6/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ GLA P06280 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853592 0.91 DHODH (0.37) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL26007994 0.90 L3MBTL1 (0.44) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL17853590 0.90 MAPT (0.40) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL17853593 0.89 DHODH (0.41) KDM4EMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL24812017 0.88 KDM4E (0.45) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL15133322 0.88 KDM4E (0.47) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL24810939 0.88 KDM4E (0.40) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL14416370 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL19397653 0.87 KDM4E (0.44) KDM4EL3MBTL1ATMMAPTALDH1A1
SCHEMBL24752756 0.87 L3MBTL1 (0.46) KDM4EL3MBTL1ATMMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 — — US disclosed
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-02-29 — — US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 KDM4E 3416/4885L3MBTL1 1876/4885ATM 3436/4885
US-20240074311-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RPS12, TCF12, RRP12 KDM4E 2161/4885L3MBTL1 785/4885ATM 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback